Cargando…

Taxonomic characterization of Pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic

In an attempt to identify novel bacterial species, microbiologists have examined a wide range of environmental niches. We describe the serendipitous discovery of a novel gram-negative bacterial species from a different type of extreme niche: a purchased vial of antibiotic. The vial of antibiotic hyg...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Timothy L., Mitra, Sumitra D., Kochan, Travis J., Pincus, Nathan B., Lebrun-Corbin, Marine, Cheung, Bettina H., Gatesy, Samuel W., Afzal, Tania, Nozick, Sophie H., Ozer, Egon A., Hauser, Alan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581066/
https://www.ncbi.nlm.nih.gov/pubmed/37737625
http://dx.doi.org/10.1128/spectrum.01838-21
_version_ 1785122071471194112
author Turner, Timothy L.
Mitra, Sumitra D.
Kochan, Travis J.
Pincus, Nathan B.
Lebrun-Corbin, Marine
Cheung, Bettina H.
Gatesy, Samuel W.
Afzal, Tania
Nozick, Sophie H.
Ozer, Egon A.
Hauser, Alan R.
author_facet Turner, Timothy L.
Mitra, Sumitra D.
Kochan, Travis J.
Pincus, Nathan B.
Lebrun-Corbin, Marine
Cheung, Bettina H.
Gatesy, Samuel W.
Afzal, Tania
Nozick, Sophie H.
Ozer, Egon A.
Hauser, Alan R.
author_sort Turner, Timothy L.
collection PubMed
description In an attempt to identify novel bacterial species, microbiologists have examined a wide range of environmental niches. We describe the serendipitous discovery of a novel gram-negative bacterial species from a different type of extreme niche: a purchased vial of antibiotic. The vial of antibiotic hygromycin B was found to be factory contaminated with a bacterial species, which we designate Pseudomonas hygromyciniae sp. nov. The proposed novel species belongs to the P. fluorescens complex and is most closely related to P. brenneri, P. proteolytica, and P. fluorescens. The type strain Pseudomonas hygromyciniae sp. nov. strain SDM007(T) (SDM007(T)) harbors a novel 250 kb megaplasmid which confers resistance to hygromycin B and contains numerous other genes predicted to encode replication and conjugation machinery. SDM007(T) grows in hygromycin concentrations of up to 5 mg/mL but does not use the antibiotic as a carbon or nitrogen source. While unable to grow at 37°C ruling out its ability to infect humans, it grows and survives at temperatures between 4 and 30°C. SDM007(T) can infect plants, as demonstrated by the lettuce leaf model, and is highly virulent in the Galleria mellonella infection model but is unable to infect mammalian A549 cells. These findings indicate that commercially manufactured antibiotics represent another extreme environment that may support the growth of novel bacterial species. IMPORTANCE: Physical and biological stresses in extreme environments may select for bacteria not found in conventional environments providing researchers with the opportunity to not only discover novel species but to uncover new enzymes, biomolecules, and biochemical pathways. This strategy has been successful in harsh niches such as hot springs, deep ocean trenches, and hypersaline brine pools. Bacteria belonging to the Pseudomonas species are often found to survive in these unusual environments, making them relevant to healthcare, food, and manufacturing industries. Their ability to survive in a variety of environments is mainly due to the high genotypic and phenotypic diversity displayed by this genus. In this study, we discovered a novel Pseudomonas sp. from a desiccated environment of a sealed antibiotic bottle that was considered sterile. A close genetic relationship with its phylogenetic neighbors reiterated the need to use not just DNA-based tools but also biochemical characteristics to accurately classify this organism.
format Online
Article
Text
id pubmed-10581066
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-105810662023-10-18 Taxonomic characterization of Pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic Turner, Timothy L. Mitra, Sumitra D. Kochan, Travis J. Pincus, Nathan B. Lebrun-Corbin, Marine Cheung, Bettina H. Gatesy, Samuel W. Afzal, Tania Nozick, Sophie H. Ozer, Egon A. Hauser, Alan R. Microbiol Spectr Research Article In an attempt to identify novel bacterial species, microbiologists have examined a wide range of environmental niches. We describe the serendipitous discovery of a novel gram-negative bacterial species from a different type of extreme niche: a purchased vial of antibiotic. The vial of antibiotic hygromycin B was found to be factory contaminated with a bacterial species, which we designate Pseudomonas hygromyciniae sp. nov. The proposed novel species belongs to the P. fluorescens complex and is most closely related to P. brenneri, P. proteolytica, and P. fluorescens. The type strain Pseudomonas hygromyciniae sp. nov. strain SDM007(T) (SDM007(T)) harbors a novel 250 kb megaplasmid which confers resistance to hygromycin B and contains numerous other genes predicted to encode replication and conjugation machinery. SDM007(T) grows in hygromycin concentrations of up to 5 mg/mL but does not use the antibiotic as a carbon or nitrogen source. While unable to grow at 37°C ruling out its ability to infect humans, it grows and survives at temperatures between 4 and 30°C. SDM007(T) can infect plants, as demonstrated by the lettuce leaf model, and is highly virulent in the Galleria mellonella infection model but is unable to infect mammalian A549 cells. These findings indicate that commercially manufactured antibiotics represent another extreme environment that may support the growth of novel bacterial species. IMPORTANCE: Physical and biological stresses in extreme environments may select for bacteria not found in conventional environments providing researchers with the opportunity to not only discover novel species but to uncover new enzymes, biomolecules, and biochemical pathways. This strategy has been successful in harsh niches such as hot springs, deep ocean trenches, and hypersaline brine pools. Bacteria belonging to the Pseudomonas species are often found to survive in these unusual environments, making them relevant to healthcare, food, and manufacturing industries. Their ability to survive in a variety of environments is mainly due to the high genotypic and phenotypic diversity displayed by this genus. In this study, we discovered a novel Pseudomonas sp. from a desiccated environment of a sealed antibiotic bottle that was considered sterile. A close genetic relationship with its phylogenetic neighbors reiterated the need to use not just DNA-based tools but also biochemical characteristics to accurately classify this organism. American Society for Microbiology 2023-09-22 /pmc/articles/PMC10581066/ /pubmed/37737625 http://dx.doi.org/10.1128/spectrum.01838-21 Text en Copyright © 2023 Turner et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Turner, Timothy L.
Mitra, Sumitra D.
Kochan, Travis J.
Pincus, Nathan B.
Lebrun-Corbin, Marine
Cheung, Bettina H.
Gatesy, Samuel W.
Afzal, Tania
Nozick, Sophie H.
Ozer, Egon A.
Hauser, Alan R.
Taxonomic characterization of Pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic
title Taxonomic characterization of Pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic
title_full Taxonomic characterization of Pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic
title_fullStr Taxonomic characterization of Pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic
title_full_unstemmed Taxonomic characterization of Pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic
title_short Taxonomic characterization of Pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic
title_sort taxonomic characterization of pseudomonas hygromyciniae sp. nov., a novel species discovered from a commercially purchased antibiotic
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581066/
https://www.ncbi.nlm.nih.gov/pubmed/37737625
http://dx.doi.org/10.1128/spectrum.01838-21
work_keys_str_mv AT turnertimothyl taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT mitrasumitrad taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT kochantravisj taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT pincusnathanb taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT lebruncorbinmarine taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT cheungbettinah taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT gatesysamuelw taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT afzaltania taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT nozicksophieh taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT ozeregona taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic
AT hauseralanr taxonomiccharacterizationofpseudomonashygromyciniaespnovanovelspeciesdiscoveredfromacommerciallypurchasedantibiotic